Corel Medical Series: Cancer/Corel Medical Series: Cancer.iso/mac/Program/Indexdat/indexa.S

Text File | 1997-01-27 | 6KB | 3 lines

S-phase testing,p02.20,Safety equipment home care,p26.4,Salivart,p18.16,Salivary gland tumor,c14a.1;c14a.7;c14b.14,Salivary glands diagram,c14b.14,Sandostatin,c08.8;c08.12;c15.10;c15.12,Sarcoid,c41.2,Sarcoma,7,Sarcoma botryoides,c46.1,Scarring post-operative,p05.20,Schwannoma,c38.2,Scirrhous carcinoma,c39.2,Screening genetic,p01.5;p37.7,Screening tests,1,Second opinion,p04.14;p05.21;p05.22,Sedatives,p19.8,Segmental resection,c06.19;c06.32,Seizures,c05.4;c05.5,Self-esteem,2,Self-examination,2,Seminoma testis cancer,c40.1,Senna,p17.24,Senokot,p17.24,Sepsis,p20.3,Serous epithelium carcinoma,c29.1,Seven Early Warning Signals (CAUTION),p02.2,Sexual practices,6,Sexuality,4,Shark cartilage,p13.12,Side effects,11,Silent period,p01.3,Silicone implants,rec.6,Sitz baths,p26.4,Skeletal lesions cancer of unknown primary site,c07.13,Skin diagram,c25.11,Skin cancer,11,Skin care,p26.9,Sleeping pills,p17.23;p23.8,Small bowel carcinoid,c08.10,Small cell carcinoma,c02.1;c31.1,Small intestine cancer ,11,Smell changes,p18.3,Smoking,9,Smoldering multiple myeloma,c28.1,Sodium,p17.24,Soft tissue and bone sarcoma ,2,Solid tumor,p35.14,Solitary myeloma of bone,c28.1,Solitary plasmacytoma,c28.2,Solumedrol for lymphoma,c24.20,Somatic pain,p19.3,Somatostatin for islet cell carcinoma,c15.12,Somatostatin-producing tumor,c15.14,Sore mouth,3,Sore throat,p20.5,Speech therapist,p03.5,Spermatocytic seminoma testis cancer,c40.1,Spinal cord tumor,c05.7;c05.23,Spiritual care,p27.7,Spirituality,p29.2;p29.6,Squamous cell carcinoma ,14,Stabilization after chemotherapy,p07.2,Staging,4,Stem cells,p07.20,Stereotactic radiosurgery,p06.8,Stereotaxic surgery,c27.8,Sterility,p12.10;p23.7;c40.26,Steroids,p19.8,Stomach diagram,c13.8,Stomach cancer,11,Stool softeners,p17.23,Stool tests,p02.8;p20.6;p34.17,Streptozocin,5,Stress,5,Stress management,p25.6,Stromal tumor ovary,c29.2,Strontium,p06.10,Sucralfate,p18.15;p18.16,Sunlight,2,Sunscreens,c37.7,Superficial spreading adenocarcinoma,c39.1,Superficial tumor,c04.4,Suplena,p18.12,Support groups,6,Suppressor genes,p01.5;p36.5;p36.10,Suramin,p35.10,Surfak,p17.24,Surgeon,1,Surgery,10,Surveillance Epidemiology and End Results (SEER) Program,p33.3,Survivors guilt,p29.8,Survivorship 209-12 ,0,Sustacal,p17.19;p18.8;p18.12,Sweat gland carcinoma breast,c06.3,Swelling,p08.17,Symptoms,5,Syngeneic bone marrow transplantation,p12.6,Syphilis,p14.3,Systemic radiation therapy,p06.10,
bone and soft tissue,c36.1,defined,p01.12,endometrial stromal,c45.1,locations,10,osteogenic,c10a.1;c10a.5,treatment,p12.23,unknown primary site,c07.1,table,chr.p34.17,restoring,p22.1,retaining,p16.12,breast,p34.17;c06.9,testis,p34.17;c40.7,anal cancer,c02.3,breast cancer,c06.5,cervical cancer,c09.3,Kaposi's sarcoma,c16.8,risk factor,p01.9;p34.8,vulvar cancer,c47.3,after treatment,p23.9,phases,p23.3,problems,p23.5,resuming activity,p23.15;p30.9,biological therapy,p08.17,body image,p16.12,bone marrow transplantation,p12.10,chemotherapy,p07.24,coping with,p17.1,hyperthermia,p10.6,hyperthermic perfusion therapy,0,of drugs,p19.9;p26.14,radiation therapy,p06.16,and stopping therapy,p07.19,and treatment options,0,causes,c37.4,diagnosis,c37.11,follow-up,c37.21,prevention,c37.7,questions to ask,c37.22,risk factors,c37.5,screening,c37.9,spread,c37.3,symptoms,c37.10,treatment,c37.13,types,c37.1,causes,c38.3,diagnosis,c38.7,questions to ask ,c38.17,recurrent,c38.16,risk factors,c38.4,screening,c38.5,spread,c38.3,staging ,c38.9,symptoms,c38.6,treatment,c38.10,types,c38.2,anal cancer,c02.3,bladder cancer,c04.4,cervical cancer,c09.6,esophageal cancer,c12.3,head and neck cancers,c14a.5,lung cancer,c20.3;c21.2,pancreas,c31.2;c31.3,risk factor,p01.7;p34.12;p34.15,and surgery,p05.14,adult,12,child,7,coping with,p17.17,from chemotherapy,p07.26;p17.17;p19.5,from radiation therapy,p06.17;p17.16;p18.14,anus,c02.1,bile duct,c03.1,bladder,c04.3,breast,c06.3,cervix,c09.1;c09.12,esophagus,c12.2,gall bladder,c13.1,lung,c20.2,neck,c14a.2;c14a.7;c14b.40,penis,c33.1;c33.8,skin,c37.1,unknown primary source,c14b.40,vagina,C46.1,vulva,C47.2,after perfusion therapy,p11.3,defined,p01.17,surgical diagnosis,p05.4,and treatment options,p01.19;p04.9,causes,c39.2,diagnosis,c39.8,questions to ask,c39.30,recurrence,c39.28,risk factors,c39.4,screening,c39.6,spread,c39.2,staging,c39.10,symptoms,c39.7,treatment,c39.11,types,c39.1,for gastrointestinal tract cancer,c08.11,for islet cell carcinoma,c08.6,for pancreatic cancer,c31.11,for small intestine cancer,c38.11,side effects,chr.p17.13,about sexuality,p23.11,negative,p25.3,positive,p25.2,resolving,p30.13,risk factor,p01.8,avoiding,p34.13,promotes cancer,p01.8;p34.7;c25.4;c37.5,cancer,p30.8,Kaposi's sarcoma,c16.23,Look GoodFeel Better,p22.4,ostomy,p21.10,sexuality,p23.3;p23.14,value of,p15.12;p16.16,role,p03.3,anesthetics,p05.15,diagnostic,p05.4,in combination therapy,p04.6;p05.6;p05.7,pain,p05.17,preparing for,p05.14,prophylactic,p05.3,purposes,p04.12;p05.3,risks,p05.19,side effects,p19.3,treatment option 31-32,0,early detection,p34.17,nursing management,p15.12,radiotherapeutic relief,p06.1,Seven Early Warning Signals,p02.2,surgical relief,p05.3,
anus,c02.1,breast,c06.3,gall bladder,c13.1,liver,c19.1,penis,c33.1,small intestine,c38.2,thyroid,c42.2,uterus,c45.1,vagina,c46.1,vulva,c47.1,causes,c36.3,diagnosis,c36.8,follow-up,c36.20,questions to ask,c36.22,recurrence,c36.21,risk factors,c36.4,spread,c36.2,staging ,c36.9,symptoms,c36.7,treatment,c36.10,types,c36.2,types (table),chr.c36.2,Ewing's sarcoma,c10d.1;c10d.10,osteogenic sarcoma,c10d.1;c10d.8,PNET,c10d.1;c10d.10,questions to ask,c10d.13,recurrence,c10d.12;c10d.9,rhabdomyosarcoma,c10d.3,types,c10d.1;chr.c10d.6,